Tags Posts tagged with "mjna"

mjna

0 1232

Medical Marijuana, Inc.’s CBD Oil RSHO-X™ Garners National News Headlines Across Mexico For Significantly Reducing Seizures Of Epileptic Children

SAN DIEGO, March 17, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Mexico garnered national news headlines across Mexico for the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of its RSHO-X™ product in treating children with severe epilepsy. HempMeds® Mexico was the first company to receive government import permits for its cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™) via the Mexican Health Department COFEPRIS.

An article from Mexico newspaper Reforma, “Ayuda cannabidiol a 84% de pacientes,” or “Cannabidiol helps 84% of patients,” explained how 84 percent of children with epilepsy treated with RSHO-X™ halved the number of seizures they suffer from, according to this first clinical study on the use of cannabis in patients with Lennox-Gastaut syndrome in Mexico.

“We are proud that our cannabidiol (CBD) hemp oil product, without THC, has enabled 17% of patients in the study to experience 100 percent relief from their seizures, the best results of any product/medication in the world regarding the reduction of seizures in Lennox-Gastaut patients,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It is exciting to see such widespread news coverage of these study results by the Mexico media, as studies that prove the therapeutic benefits of CBD like Dr. Garza’s study will continue to help fuel less restrictive medical cannabis programs not only in Mexico, but across the globe. In addition, as news spreads of this revolutionary treatment for diseases such as epilepsy, more patients and families that suffer from debilitating medical conditions will receive help with medical marijuana.”

The study included 39 patients with Lennox-Gastaut syndrome, a severe form of pediatric epilepsy that typically develops before the age of 4. Of those 39 patients, who took up to 5-7mg CBD/kg progressive doses of RSHO-X™ 5000MG, 84% experienced a 50% or greater reduction in motor seizures; 53% reported better than a 75% reduction in seizures; and seven reported a complete elimination of all seizures (17%) over a four-month period, with zero reported side effects.

Results of this study are set to be published in the near future. To view the study, click here.

Other major national Mexico outlets that have reported the results of Dr. Garza’s epilepsy study with RSHO-X™ include:

Contenido

Economiahoy.mx

El Diario.mx

El Imparcial

El Mural

El Universal

Frontera.info

La Cronica

La Jornada

Radio Centro

Yahoo Mexico

Zocalo

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

CONTACT:
Public Relations Contact: Andrew Hard
Chief Executive Officer
CMW Media
P: 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com

0 2570

Monday (3/14), one of the cannabis industry leaders, GW Pharma (GWPH) announced positive results from its first Phase 3 study of Epidiolex in the treatment of Dravet syndrome. Epidiolex already has orphan drug designation and Fast Track Designation from the FDA for this rare form of epilepsy. Currently there are no treatments approved in the U.S. The Active substance in Epidiolex, cannabidiol or CBD, has been the source of conversation and controversy for years.

Many doctors have even condemned it as a false therapy for things like cancer and, yes, epilepsy. But with the advent of strains like Charlotte’s Web, which have shown to drastically curb the affects of epilepsy, these Phase 3 results may confirm much of what many in the health community has already confirmed, which is that CBD’s can be a strong reactive therapy for debilitating diseases like this.

These findings could mean big things for the marijuana industry, as the ripple effect seems to have already begun. GW Pharma stock sprinted 120% to 84.71 in the stock market Monday, hitting a three-month high above 91, intra-day. The news also jump started other cannabis-related stocks like Insys Therapeutics (INSY), which rose 11% to 18.89, and the recently IPO’d Zynerba Pharmaceuticals (ZYNE), which increased to a six month high of $21.08; up 150%.

Like GW Pharma, Insys is also testing a CBD product in Dravet syndrome, and similarly has been granted an orphan-drug designation from the FDA. Zynerba is developing a form of CBD that can be applied through the skin. In a recent PR, ZYNE reported that in the first half of 2016, the Company expects to report final results from its ongoing Phase 1 single rising dose clinical trial, including results from 12 patients with epilepsy.

Other CBD Related Stocks Seeing More Attention From GW’s Findings:

FBEC Worldwide, Inc. (FBEC)

Originally focused on providing hemp based energy drinks, FBEC has also spread its reach into the quality CBD marketplace through its distribution of Ma Brand CBD. Late last year the company signed a Joint Venture agreement with CBD Globe Distributors Ltd. in which FBEC will own 50.1% of the newly formed Joint Venture LLC and receive 50% of the net profit from its operations. According to CBD Globe, it has invested over $200,000 in production and development of the Ma brand itself and already has 10,000 units packaged and ready for sale. The CBD vaping product has a highly refined CBD oil made from hemp, grown in the United States.

Top UFC contender, Anthony “Rumble” Johnson, has endorsed the company’s hemp energy shot product. Furthermore, its most recent announcements have dealt heavily with revamping its share structure and curbing potential sources of future dilution. FBEC shares rose just over 25% from Monday’s open and closed at the high of day.

GreenGro Technologies, Inc. (GRNH)

GRNH also acquired Greensticks, Inc.; a patent pending technology for an electronic vaporizer for Cannbidiol (CBD). Branded as a new way to medicate, Greensticks is a battery powered electronic vaporizer designed to look like an electronic cigarette. The cartridges are filled with 100% organic liquefied flowers and pharmaceutical grade glycol as found in asthma inhalers.

GRNH recently announced record-breaking 242.94% year-over-year sales growth through the first quarter of 2016. According to the company, this timely growth came as a result of new customers along with renewals and the ongoing expansion of the company’s product lines. Additionally, sales increased by 209.57% from the fourth quarter of 2015 to the first quarter of 2016. Along with many other marijuana stocks, GRNH shares increased by nearly 60% from open to high and closed the Monday session at its HOD of $0.349 on more than 5 times it’s average 30-day volume.

Medical Marijuana Inc. (MJNA)

This marijuana stock saw very heavy volume on Monday with price increasing by a modest 7% from its previous close, Friday. The company announced at the beginning of March that its portfolio investment company, KannaLife Sciences, Inc. has received the necessary 2016 quota allotment from the U.S. DEA to import high-purity, pharmaceutical-grade cannabidiol into the U.S.

KannaLife is currently focused on the feasibility studies with Catalent Pharma to develop a cannabinoid-derived therapeutic agent for the treatment of two neurodegenerative diseases: Hepatic Encephalopathy and Chronic Traumatic Encephalopathy; forms of brain degradation in humans that can be due to things like head trauma.

Cannabis Science, Inc. (CBIS)

This stock saw an incredible day on Monday as well. The stock increased from an opening price of $0.01 to a high of $0.0194. The stock ended the day, closing up just under 50%. The company is continuing testing and providing limited rollouts for its own CBD-based treatment products in California. The company has taken a strong stance to increase shareholder value.

In recent press Cannabis Science’s CEO announced that he will be gifting his own shares to shareholders in lieu of previously announced dividends. That date of record for shareholders has been extended to March 31, 2016.

CV Sciences. (CANV)

The stock saw nearly 3 times its average 30-day volume on Monday fueled by excitement in the marijuana sector. Share prices rallied up more than 75%. In most of the recent press releases, the company has been focused on extinguishing the remainder of its convertible debt and as of early March, CANV management confirmed that 100% of the outstanding convertible promissory notes have been retired.

Following the acquisition of CanX and Canabine earlier this year, the company has taken a firm stance on efforts to develop synthetically-formulated CBD for use in drug development activities. In particular, they are looking to pursue approval of the FDA for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. Board Chairman James A. McNulty has been an active contributor to biotechnology and health care related companies, including BioDelivery Sciences International, Inc. (BDSI), Hedgepath Pharmaceuticals, Inc. (HPPI), Accentia Biopharmaceuticals, Inc., and Biovest International, Inc. He is also a former shareholder of CanX, which brings this full circle.

Conclusion

There are obviously many more marijuana stocks that could be mentioned here but it would seem that the CBD-centric companies like those mentioned, have begun to benefit from the latest ground breaking announcement that GW Pharma has just made with regard to a successful Phase 3 study. With such a late stage success, we think that the hemp, CBD and cannabis space will be a topic of major discussion in 2016.

 

 

Additional disclosure/disclaimer

An affiliate of MAPH Enterprises, LLC MarijuanaStocks.com | WolfofWeedStreet.com was paid an advertising fee of $60,000 cash & 60 Million Restricted Common shares by FBEC Worldwide Inc. (FBEC) for visual sponsorship of MarijuanaStocks.com | WolfofWeedStreet.com and for visual placement FBEC Worldwide Inc. (FBEC) within written materials. FOR A DURATION OF 5 YEARS BEGINNING JUNE 2015 ending JUNE 2020

0 1433

Medical Marijuana, Inc.’s HempMeds(R) Signs U.S. Manufacturer Sales Agreement for Over $2,500,000 – Ships First Two Months Supply of 12 Month Contract

SAN DIEGO, Sept. 9, 2015 (GLOBE NEWSWIRE) — HempMeds(R), a Medical Marijuana, Inc. (OTC Pink:MJNA) portfolio company and the Company’s master distributor, is pleased to announce to shareholders and the public that it has signed a U.S. manufacturer for sourcing of its Gold Label cannabidiol (CBD) hemp oil brand Real Scientific Hemp Oil(TM) (RSHO(TM)). The sourcing agreement is for a minimum of $2,500,000 USD for a 12-month period. The first two months of the contract have already been sold, shipped and processed.

The new manufacturer has develop finished natural CBD hemp oil products for both people and pets — and represents an additional new revenue stream for the Company.

“The Company has been working diligently on developing the appropriate sales and distribution strategies,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “This is part of our strategy to scale and grow HempMeds’ sales and bring significant new revenue into the Company. This is the second major contract the company has executed in the past few months, first was the launch of Korea sales channels and this is the second. Our team has been working very hard to secure and develop additional large scale contracted supply agreements in order to diversify our sales channels.”

Hemp is widely regarded as a “whole food” and “super food.” MJNA’s cannabidiol (CBD) hemp oil is derived from the mature stalk of the hemp plant and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic/euphoric effects of THC.

An industry innovator and pioneer at the global level, HempMeds(R) is the primary sales and marketing arm for Medical Marijuana, Inc. Hemp oil products from HempMeds(R) are readily available to ship to all 50 U.S. states, districts and territories plus more than 40 countries around the world.

For more information on HempMeds and their all-natural hemp oil products, visit: www.hempmeds.com. The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds(R) through the Company’s social media websites on Facebook and Twitter.

The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s video statement, click here.

About HempMeds

HempMeds(R) offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds(R) is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds(R) is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

Contact:
Public Relations contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 858-380-5478
andrew.hard@cmwmedia.com
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations:
GH Investment Advisors
550 West “C” Street, Ste. 2040
San Diego, CA 92101
Nick Massalas
Office: (858) 264-6500
Toll Free: (877) 964-6463
info@ghinvestmentadvisors.com

0 1939

Photo Release — Medical Marijuana, Inc. Relocates Dixie Botanicals From Colorado to California

Cannabis’ Most Recognized Brand Brings Cannabidiol (CBD) Hemp Oil Products and Economic Development Opportunities to All 50 States and More Than 40 Countries

SAN DIEGO, Feb. 11, 2015 (GLOBE NEWSWIRE) — The booming cannabis industry is known to entrepreneurs as the “Green Rush” and, today, Medical Marijuana, Inc. (OTC Pink:MJNA) is announcing a mother lode. In an historic move, Medical Marijuana, Inc., a hemp industry innovator, is relocating from Colorado to California one of the most recognized brands in the cannabis industry and the world: Dixie Botanicals(TM).

Dixie Botanicals(TM) Dew Drops Hemp Oil Supplement

View photo

.

Dixie Botanicals(TM) Dew Drops Hemp Oil Supplement 500 mg in cinnamon and natural flavors.

Photos accompanying this release are available at

http://www.globenewswire.com/newsroom/prs/?pkgid=30644

http://www.globenewswire.com/newsroom/prs/?pkgid=30645

http://www.globenewswire.com/newsroom/prs/?pkgid=30646

http://www.globenewswire.com/newsroom/prs/?pkgid=30647

Through Medical Marijuana, Inc.’s ownership and leadership, Dixie Botanicals(TM) is further evolving its hemp cannabidiol (CBD) oil product line development for expanded national and global distribution.

“Moving the well-known and well-respected brand, Dixie Botanicals, from Denver, Colorado — what is viewed by many as the ‘epicenter’ of the national recreational and medical cannabis movement — to San Diego, California, should make it abundantly clear to the public that the hemp cannabidiol variety of cannabis can be enjoyed freely across state lines,” states Michelle Sides, Chief Operating Officer of Medical Marijuana, Inc.

Sides continues, “Dixie Botanicals’ consumers have come to expect raw ingredients and finished products of the highest quality. We are pleased to announce that the only change that Dixie Botanicals’ consumers will notice is a new product label and new products in the future. Dixie Botanicals consistently provides the same non-GMO, all-natural, and high-quality product with each purchase.”

The non-psychoactive CBD hemp oil Dixie Botanicals(TM) product lines currently include:

The popular brand’s customer service, sales and marketing teams are now fully operational in San Diego’s Poway area and are already actively servicing clients from around the world. Future growth will translate to a greater national presence and foster additional employment and economic development opportunities for the local community as well as retailers across the globe.

To learn more about Dixie Botanicals(TM), click here.

About Dixie Botanicals

Regarded as one of the most well recognized brands in the industry, Dixie Botanicals(TM) offers innovative hemp oil products for health conscious consumers. Our formulation experts include scientists, clinical herbalists and nutritionists who work to integrate our hemp oil into a variety of unique products. Dixie Botanicals’ products contain naturally occurring cannabidiol (CBD) hemp oil from the mature stalk of the industrial hemp plant. We test and analyze our products from seed to shelf, ensuring that every natural product we offer is free from contaminants and of the highest quality possible. (Click to view test results.) For more information, visit:www.DixieBotanicals.com.

About Medical Marijuana, Inc.

Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:www.MedicalMarijuanaInc.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

The photos are also available at Newscom, www.newscom.com, and via AP PhotoExpress.

Contact:
For further information, please contact:
Investor Relations contact:
Perry Coleman
Medical Marijuana, Inc.
P. 443-453-5088
perry@medicalmarijuanainc.com
Public Relations contact:
Andrew Hard
CMW Media
P. 858-380-5478
andrew.hard@cmwmedia.com
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

0 1322

Photo Release — Medical Marijuana, Inc.’s Kannaway Continues National Expansion

Kannaway Brings Retail-Ready Hemp Cannabidiol (CBD) Products to Miami, Orange County, and Atlanta

GlobeNewswire

SAN DIEGO, Feb. 9, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc.‘s (OTC Pink:MJNA) Kannaway(TM), is rapidly ramping up its mission to bring hemp back to consumers across the nation. Today, Kannaway(TM) announced plans to open three new regional offices in Miami, Orange County, and Atlanta before the end of May 2015. These national expansion plans follow the recent Texas office openings in Houston and Dallas.

Rev!ve(TM)

View photo

.

New Rev!ve(TM) PRO all-natural hemp CBD oil supplement

Photos accompanying this release are available at

http://www.globenewswire.com/newsroom/prs/?pkgid=30576

http://www.globenewswire.com/newsroom/prs/?pkgid=30577

http://www.globenewswire.com/newsroom/prs/?pkgid=30578

http://www.globenewswire.com/newsroom/prs/?pkgid=30579

http://www.globenewswire.com/newsroom/prs/?pkgid=30580

“The Kannaway team couldn’t be more excited to bring our natural hemp lifestyle products to these cities. Opening new regional Kannaway corporate offices in these major cities is the next step in continuing the Company’s growing momentum and restoration of hemp-based products in the domestic economy,” states Jeff Rogers, CEO of Kannaway.

Kannaway’s strong physical presence in Texas, California, Florida, and Georgia, is giving consumers a wide variety of everyday use hemp CBD oil product options. As of 2015, 23 states and the nation’s capital, DC, all have laws permitting access to medical marijuana, which is a cousin to the non-psychoactive hemp plant. Although Florida’s Amendment 2–which would have legalized medical marijuana for the state–did not pass this past November, Kannaway’s products offer Florida consumers the possibility to purchase retail-ready CBD hemp oil products today.

The current all-natural CBD hemp oil products available through Kannaway(TM) include:

  • rev!ve(TM) – advanced nutrition supplement
  • Cannabis Beauty Defined(TM) – anti-aging skincare line
  • KannaKick(TM) – functional energy food chew
  • Kannactiv(TM) – 3-step daily skin care system for troubled skin
  • HempVAP(R) – first hemp-based CBD oil vaporizer pen on the market

Rogers continues, “Our company is excited to announce these cities are the newest additions for the ‘Kannaway nation’. We look forward to offering these communities new business and economic growth opportunities by capitalizing on the growing demand for natural hemp lifestyle products. The attention given to the Dallas office opening is a great indicator for the potential with new regional office locations.”

Tens of thousands of Kannaway(TM) Brand Ambassadors and marketing specialists make up the “Kannaway Nation.” The Company’s initiative is to educate the masses on industrial hemp’s practical applications in the everyday lives of consumers. Millions have learned about the return of hemp through Kannaway(TM) in mainstream publications including USA Today and Fortune Magazine.

To learn more about Kannaway(TM), visit the Kannaway website.

About Kannaway, LLC

Kannaway(TM), LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway(TM) currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:www.MedicalMarijuanaInc.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

Photos are also available at Newscom, www.newscom.com, and via AP PhotoExpress.

Contact:
For further information, please contact:
Investor Relations contact:
Perry Coleman
Medical Marijuana, Inc.
P. 443-453-5088
perry@medicalmarijuanainc.com
Public Relations contact:
Andrew Hard
Spokesperson
P. 858-380-5478
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

1 1287

Photo Release — Medical Marijuana, Inc.’s Kannaway Appoints Wes Bishop to Field Advisory Council

Proven Global Network Marketing Business Builder Takes Charge of New Dallas Office

SAN DIEGO, Feb. 3, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc.‘s (OTC Pink:MJNA) Kannaway’s executive team is proud to announce the addition of Network Marketing leadership expert, Wes Bishop. Bishop’s past military service with the United States Navy first introduced him to the importance of strong team dynamics and inspiring leadership. After his military career, Bishop became a sales leader in a diverse range of industries including real estate, network marketing, and even the cellular industry. Bishop now has over 25 years of experience leading and developing dynamic teams.

“I joined Kannaway because this is the first time a product in the network marketing industry is changing the way people look at their own health and wellness. The Company is giving individuals the unique opportunity to not only empower themselves through entrepreneurship, but to also be a part of an historic movement rooted in education and improvement. They’re the ones bringing hemp back to America,” states Wes Bishop.

“We are excited to welcome Wes Bishop to the Kannaway family,” said Jeff Rogers, CEO of Kannaway. “He is an incredible leader who has built teams of thousands in Network Marketing. We couldn’t have selected a better man than Wes Bishop to lead our Dallas Regional Office. What he’s done there in such a short period of time is nothing short of amazing. The success of Kannaway’s Dallas regional launch event was in large part due to Wes and his Dallas team.”

Kannaway’s Dallas regional launch event was Jan. 24 and featured new product announcements, guest speakers Troy Dooly and Janelle Kim, and exciting announcements about the Company’s future with Medical Marijuana, Inc.

To learn more about Kannaway visit the Kannaway website.

About Kannaway, LLC

Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:www.MedicalMarijuanaInc.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.

Contact:
For further information, please contact:
Investor Relations contact:
Perry Coleman
Medical Marijuana, Inc.
P. 443-453-5088
perry@medicalmarijuanainc.com
Public Relations contact:
Andrew Hard
Spokesperson
P. 858-380-5478
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

1 1718

Photo Release — All Eyes on Kannaway: Dallas Launch Creates New Cannabis-Based Economic Development Opportunities

Fast-Growing Network Marketing Company Announces Business Opportunities, Employment and Cannabis Products at Historic Press Conference in Dallas, Texas

 SAN DIEGO, Jan. 27, 2015 (GLOBE NEWSWIRE) — Kannaway, LLC is the first hemp lifestyle network marketing company to offer cannabidiol (CBD) oil products. Prior to the San Diego headquartered company expanding its footprint to include its first regional office in Dallas, Texas, members of the media were invited to an historic Jan. 23 press conference announcing cannabis’ arrival in the Lone Star State. Veteran reporter Steve Picket of CBS Dallas reports, “There is no question this is legal because we are not talking about marijuana use.” Picket continues in his live report, “We are talking about cannabis and particularly hemp oil.”
Rev!ve PRO

View photo

.

Kannaway’s Rev!ve PRO all-natural cannabidiol (CBD) hemp oil supplement

Photos accompanying this release are available at

http://www.globenewswire.com/newsroom/prs/?pkgid=30303

http://www.globenewswire.com/newsroom/prs/?pkgid=30304

http://www.globenewswire.com/newsroom/prs/?pkgid=30306

http://www.globenewswire.com/newsroom/prs/?pkgid=30305

At the press conference, members of the media were introduced to a 4-year-old Dallas-area cannabis consumer, Harper Elle Howard. Born with a rare genetic debilitating condition that has no known cure, Harper’s parents researched cannabis use after watching a documentary. Not being able to access medical marijuana in their state and not being willing to move to another legalized medical marijuana state, the Howard family found an alternative hemp-based CBD oil product that is available online and ships to all 50 states. Hope4Harper.com, lists Harper’s cannabis use on the website’s blog giving hope and educating others around the world. Kannaway is a corporate supporter of Hope4Harper.com and invited the media to learn that the cannabis consumer profile spans individuals of all ages.

“It has zero to do with getting high,” states Kannaway CEO Jeff Rogers in an interview with Mike Albanese of Dallas’ Star Local Media. Albanese’s report Cannabis Company Opens Its Doors in Dallas shares U.S. hemp history dating back to the country’s founding fathers and Henry Ford’s use of the versatile plant for automobiles. He also reported on little Harper Howard’s experience with the ancient plant, how it has impacted her life and how the Dallas community has rallied behind her in support.

It is clear that Kannaway is on a mission to return the innovative hemp plant to the domestic economy. The Company has tens of thousands of marketing Brand Ambassadors who are carrying the message to households coast-to-coast. At Kannaway’s Dallas regional launch event, there were new product announcements including:

Guest speaker, Troy Dooly, wowed the “Kannaway Nation” with his knowledge of network marketing and Kannaway’s position in the industry as a “category creator” of CBD hemp oil products. The Company’s creator of Bi-Bong(TM) herbal extracts, Janelle Kim, explained to the Dallas audience why all-natural products work well with CBD hemp oil resulting in one-of-a-kind products.

Kannaway also announced at its Dallas regional launch the pending acquisition by Medical Marijuana, Inc. (OTC Pink:MJNA), a publicly traded icon in the cannabis industry. A pre-acquisition valuation of Kannaway by one of the top firms in the business indicated that the Company was worth up to $242 million.

When asked about the acquisition by Juliette Fairley of New York’s MainStreet.com, Edgar Montero, VP of International Expansion for Kannaway, states “We are looking to introduce nutritional products in the form of powders, proteins, supplements and sports drinks made with CBD, hemp proteins and other natural, organic and non-GMO compounds.” Fairley states in the interview that, “CBD refers to cannabidiol, a compound in cannabis that is described as having medical effects without getting users high.”

“The Kannaway launch in Dallas was historic,” concludes Kannaway CEO, Jeff Rogers. “The Company chose Dallas as its first regional satellite office for its central location. However, being in a non-medical marijuana state, we knew there would be questions raised by the public. We are extremely appreciative to the news media for explaining to viewers and readers the key reasons that hemp CBD oil products are available in all 50 states.”

Where is Kannaway headed next? The hemp lifestyle company’s sites are set on Miami over the cannabis industry’s historic “420 weekend.” For more information on Kannaway(TM), visit the Company website.

About Kannaway, LLC

Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:www.MedicalMarijuanaInc.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

The photos are also available via Newscom, www.newscom.com, and via AP PhotoExpress.

Contact:
For further information, please contact:
Investor Relations contact:
Perry Coleman
Medical Marijuana, Inc.
P. 443-453-5088
perry@medicalmarijuanainc.com
Public Relations contact:
Andrew Hard
Spokesperson
P. 858-380-5478
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

0 1706

Photo Release — Medical Marijuana, Inc. Signs Definitive Agreement to Acquire Kannaway, LLC

$119.6-242.7 Million Valuation by Houlihan Capital, a Firm That Performed Similar Valuations for U.S. Airways, Inc. and Redbox 

SAN DIEGO, Jan. 22, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), a leading industrial hemp industry innovator, is proud to announce that it has signed a definitive agreement to acquire 100% membership interest of Kannaway, LLC. The amount of the sale is undisclosed. The valuation of Kannaway is in the range of $119.6-242.7 million USD. The agreement is expected to take at least 90 days to close and will effectively make the cannabis-based network marketing company a wholly owned subsidiary of the first-ever publicly traded cannabis company.

Kannactiv

View photo

.

All-natural Kannactiv for troubled skin

Photos accompanying this release are available at

http://www.globenewswire.com/newsroom/prs/?pkgid=30230

http://www.globenewswire.com/newsroom/prs/?pkgid=30231

http://www.globenewswire.com/newsroom/prs/?pkgid=30232

http://www.globenewswire.com/newsroom/prs/?pkgid=30233

Kannaway’s valuation was performed by none other than esteemed financial advisory and investment banking firm, Houlihan Capital. The firm has performed valuations for similar category creators including: Urban Outfitters, Redbox, Micros Systems Inc., LeapFrog Enterprises, Tootsie Roll Enterprises, U.S. Airways Inc., and more. Houlihan Capital is a Financial Industry Regulatory Authority (FINRA) and SIPC member, committed to the highest levels of professional ethics and standards.

“Quality, ethics and accountability are hallmark principles that are the foundation for each Medical Marijuana, Inc. company,” states Michelle Sides, Chief Operating Officer of Medical Marijuana, Inc. “We are thrilled at the addition of Kannaway to Medical Marijuana, Inc.’s investment portfolio as the Company’s leadership operates under the same beliefs. Kannaway offers Medical Marijuana, Inc. shareholders a unique, built-in educational and distribution network comprised of tens of thousands of Kannaway’s Brand Ambassadors. Together we look forward to writing a new chapter in global hemp history.”

Kannaway first stood out when it reported issuing nearly $1,000,000.00 USD in commission andattracting more than 70,000 enrollees within its first 88 days of operation. Kannaway’s mission to educate the masses on hemp history in America has gained an enormous following of hemp lifestyle enthusiasts, also known as the “Kannaway Nation,” which continues to grow.

Also growing is cannabis’ popularity; trends for 2015 include cannabis in the top 10 natural products to watch in 2015. As of the November elections, there are 34 states that have some form of cannabis accessibility on the books. Meanwhile, Kannaway’s innovative hemp CBD oil lifestyle products are sold in all 50 states.

When asked about the transition, Kannaway CEO Jeff Rogers states: “We are excited to be joining such an amazing family of companies. Medical Marijuana, Inc., is the leader in the cannabis industry. Having that clout behind us takes Kannaway to the next level and gives us added credibility to attract top leaders in the network marketing industry as we continue to pioneer and be the category creator within our space.”

Rogers continues, “From an investor’s perspective, Kannaway provides an opportunity to participate in an historic initiative to restore hemp freedom to the consumer wherever Kannaway products are sold – and help leave a mark on U.S. history.”

Tens of thousands of Kannaway Brand Ambassadors and marketing specialists make up the “Kannaway Nation.” The Company’s mission is to educate the masses on industrial hemp’s practical applications in the everyday lives of consumers. Millions have learned about the return of hemp through Kannaway in mainstream publications including USA Today and Fortune Magazine.

To learn more about the Company, visit Kannaway’s News website.

About Kannaway, LLC

Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:www.MedicalMarijuanaInc.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.

Contact:
For further information, please contact:
Investor Relations contact:
Perry Coleman
Medical Marijuana, Inc.
P. 443-453-5088
perry@medicalmarijuanainc.com
Public Relations contact:
Andrew Hard
Spokesperson
P. 858-380-5478
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

7 8407
marijuana stocks

After a wild year for marijuana stocks in 2014,

many of our viewers and members contacted us asking for our opinion and outlook for 2015. So what did we do? The MarijuanaStocks.com team sought out the advice of an experienced, professional hedge fund trader to see how he was maneuvering this market. The following is his report. Enjoy. We sure did.

Trade and Run or Buy and Hold?

Marijuana Plant or Biotech?

Many people have asked me what the best way to invest in the marijuana industry is. My response is not one specific company but rather an overall strategy based on different niche sectors that has allowed me to profit quite handsomely from a market overflowing with uncertainty, regulation and volatility. Understanding how each niche sector is effected by the evolving industry and how investors react regarding the different risk factors of each sector is key.

I compare the Marijuana Industry to the Internet Boom. The similarities from an investment stand point are eerily similar. Although the Internet was not bound by regulation, the volatility and investor craze was unlike anything I’ve ever seen in my career. But you could NOT just simply put your money into any new Internet company and not check it for a year or two. Maybe 90% of the Internet IPOs failed. But that doesn’t mean there wasn’t massive amounts of money to be made trading them. Then, as the industry developed, matured and the potential of the Internet was fully understood by investors, the Apples, Microsofts, and Yahoos began to separate themselves from the rest of the pack. And those were the companies that you could put your money in and not look at it for years to come.

But when an industry is just starting, as the marijuana sector literally is before our eyes, it is nearly impossible to identify the future leaders when there is so much speculation and outside factors like regulatory issues state by state and by the overall government. That is why I am not holding one single “marijuana company” yet. I am trading them. Why? Because any company that is directly affected by regulation of the cannabis plant is not a safe long-term investment, yet. And I stress the word yet because eventually the industry will mature enough to where a select few marijuana companies will be a buy and hold. But for now, trade the volatility. Get in and get out. During the last 8 months, I am averaging 2-3 day holding periods on cannabis stocks.

Now, there is, however, another niche sector of the cannabis revolution that has been a buy and hold. And that is because it is in no way affected by the regulation of the actual marijuana plant. That sector is biotech. Companies using cannabinoid structures to produce various drugs and medicines to treat specific ailments and hopefully achieve FDA approval. To date, this is the only sector of the cannabis revolution, in my opinion, that has been a safe long term investment.

Volatility levels are nowhere near like what we see in marijuana companies. And that is because the success of a biotech company’s stock is much more determined by the company’s ability to execute on their business plan. A marijuana company can execute their business plan quickly and efficiently and receive proper licensing but will still see negative performance if a major regulatory event hinders the industry. Similar to the overall sell-off we saw in marijuana companies when Florida declined the use of medical marijuana. This is why you must trade these companies quickly. There are too many outside factors that will affect your investment.

Biotech vs. Marijuana

When looking at biotech companies operating in the cannabis space, you see a very steady and solid long term uptrend. On the other hand, when looking at marijuana companies dealing with the plant or ancillary products, you see a distinct long term downtrend with several quick momentum building trades mixed in between. Here are a few examples of what I’m talking about:

Biotech

There are two clear leaders in the cannabis revolution and they are both biotech companies. Neither company actually touches the marijuana plant itself and are not held to the same restrictions and regulatory exposure. This has allowed these two companies to execute on their business plans free of outside risk and uncontrollable factors making them safe long term investments to this point. In addition, the biotech sector is the only niche cannabis sector to see institutional support giving the retail investor a sense of security. Now, of course every stock will have its ups and downs, but the point to take from this is that the biotech sector is the only sector of the marijuana revolution still holding significant gains over the past 12 months or longer.

GW Pharmaceuticals (GWPH)

gwph marijuana stock

INSYS Therapeutics Inc. (INSY)

insy

GWPH and INSY are both sporting solid, consistent uptrends while posting gains well over 500% for those who bought and held over the last 12-24 months. The biotech cannabis sector has proven to be the only niche sector to maintain a long term uptrend making it the only sector, to date, worth holding.

Marijuana

Companies dealing directly with the marijuana plant and/or its ancillary products, have been extremely volatile providing excellent trade opportunities. However, anyone who used the buy and hold model in this sector is left with near worthless investments. This is a direct result of the unknown risk element involved with regulatory actions and investors trying to understand how the state by state approval/denial of medical/recreational marijuana will effect a company’s business model.

Medbox Inc. (MDBX)

mdbx

Medbox would be placed in the ancillary products niche sector. As you can see, MDBX has experienced a severe downtrend over the last 12 months. However, there have been several very profitable quick trades throughout 2014. Take your profits and move on. Anyone who left their money in MDBX for an extended period of time saw their investment melt away.

Medical Marijuana, Inc. (MJNA)

mjna

Medical Marijuana, Inc. has experienced a distinct downtrend for the past 12 months with a couple profitable trades mixed in between. Throughout the entire year, there was only one instance where it was safe to hold MJNA for longer than 4 days.

Cannabis Science Inc. (CBIS)

cbis

Cannabis Science, too, has been in an overall downtrend for the past 12 months with a few profitable trades throughout.

The list of marijuana companies in a downtrend goes on and on with many charts depicting a very similar picture as the ones above. This even stretches into the vapor industry, another ancillary marijuana sector.

Summary

The marijuana industry is growing, but is still in its infancy stage. Similar to what we saw during the Internet Boom, as time progresses I expect to see companies separate themselves from the pack while others fade away into oblivion. Until the outside, uncontrollable risk factors are not as much of a catalyst, marijuana companies will remain nothing more than quick trades for me. But I stress, I am very positive on the future of this industry. I simply think it is still young. As the sector develops, the opportunity for long term buy and hold investments will become clearer.

But as of today, my buy and hold strategy will be in the biotech cannabis space as they are not subject to the regulatory exposure that has proven detrimental to a company’s stock. I will continue to trade the momentum and volatility of marijuana companies because they do provide excellent liquidity and profitable opportunities. But I will likely not hold a position longer than 4-5 days at a time.

0 1544

Photo Release — CanChew Gum Gives Holiday Cheer Through Adopt-A-Soldier

Company Donates Award-Winning Hemp Cannabidiol (CBD)-Infused Gum to U.S. Service Members

SAN DIEGO, Dec. 23, 2014 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), a leading industrial hemp industry innovator, is proud to announce that its joint venture company, CanChew Biotechnologies, LLC (CanChew(R)), is spreading holiday cheer to U.S. service members through the Adopt-A-Soldier program. The Company’s Adopt-A-Soldier representative will be giving CanChew(R) gum to our national heroes, soldiers, sailors, airmen and Marines.

CanChew Gum

View photo

.

Award-Winning CanChew Hemp CBD Gum

A photo accompanying this release is available athttp://www.globenewswire.com/newsroom/prs/?pkgid=29763

“Our service members give so much and we are honored to give back to them in such a unique way,” states Andrew Hard, spokesperson for Medical Marijuana, Inc. “We have donated a generous supply of great-tasting, award-winning CanChew(R) mint hemp CBD gum to the Adopt-A-Soldier program. We’re honored to give a donation to our troops for the holidays, and to try our best to honor their sacrifices and everything they do for our country, every day of the year.”

CanChew(R) is a hemp cannabidiol (CBD) oil-infused chewing gum that is distinctly different than other brands of gum on the market. Features listed on the CanChew(R) website include:

  • Non-habit forming
  • No prescription needed
  • Available in all 50 states
  • Great-tasting mint gum has no artificial sweeteners or preservatives
  • Non-GMO, gluten free, vegan and kosher

Already an industry leader and innovator, 2014 was a big year for CanChew(R), which was also recognized by the HealthyLivinGFoundation and honored with its Triple Leaf Award. CanChew(R) was also featured in Healthy Living Magazine‘s December issue.

With so much good news in 2014, and a lot more exciting updates to come in 2015, it was time to give back a little bit.

Hard concludes, “We are honored and thrilled to spread uplifting holiday cheer to our service members. From our Company, its supply chain and employees, we wish every one of our service members and their families the very best this holiday season and in the New Year.”

For more information visit the Company’s website at www.CanChewGum.com.

About Medical Marijuana, Inc.

Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:www.MedicalMarijuanaInc.com.

About CanChew Biotechnologies

CanChew Biotechnologies focuses on the treatment of pain and other medical disorders with the application of cannabinoid medical products as well as food and nutraceutical products for general well-being.

The company is focused on the R&D and execution of their clinical development plan and potential out-licensing of their technology. Clinical development focuses on the R&D of the formulation, production and the development of chewing gum-based products for the treatment of conditions like pain, nausea and vomiting, anorexia, spasticity and various other medical issues. For more information on the company, visit CanChewGum.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.

Contact:
For further information, please contact:
Investor Relations contact:
Perry Coleman
Medical Marijuana, Inc.
P. 443-453-5088
perry@medicalmarijuanainc.com
Public Relations contact:
Andrew Hard
Spokesperson
P. 858-380-5478
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements